On Friday, the District Court for the Middle District of North Carolina issued a ruling invalidating specific claims in two patents that Natera Inc. NTRA asserted against NeoGenomics, Inc.'s NEO v1.1 RaDaR test.Natera said on Friday that it is evaluating its options, including an appeal and further enforcement with other patents.Natera said these patents are distinct from U.S. Patent No. 11,519,035 (the ‘035 patent), and the decision has no impact on the validity or enforceability of the ‘035 patent.The ‘03 ...